Cargando…
Mitochondrial Metabolism in Pancreatic Ductal Adenocarcinoma: From Mechanism-Based Perspectives to Therapy
SIMPLE SUMMARY: In cancer therapy, mitochondrial metabolism has emerged as a particularly attractive target, especially for malignancies such as pancreatic ductal adeno carcinoma (PDAC) that are resistant to treatment. Along with other treatment approaches, including targeting glutamine and fatty ac...
Autores principales: | Padinharayil, Hafiza, Rai, Vikrant, George, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954550/ https://www.ncbi.nlm.nih.gov/pubmed/36831413 http://dx.doi.org/10.3390/cancers15041070 |
Ejemplares similares
-
Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
por: Rai, Vikrant, et al.
Publicado: (2020) -
Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019) -
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
por: Gurreri, Enrico, et al.
Publicado: (2023) -
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
por: Kung, Heng‐Chung, et al.
Publicado: (2023) -
Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
por: Karimnia, Vida, et al.
Publicado: (2021)